| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/0891-5849(88)90052-4 |
| P698 | PubMed publication ID | 2966094 |
| P2093 | author name string | Bartosz G | |
| Kedziora J | |||
| P433 | issue | 5 | |
| P921 | main subject | pathology | Q7208 |
| reactive oxygen species | Q424361 | ||
| P304 | page(s) | 317-330 | |
| P577 | publication date | 1988-01-01 | |
| P1433 | published in | Free Radical Biology and Medicine | Q5500023 |
| P1476 | title | Down's syndrome: a pathology involving the lack of balance of reactive oxygen species | |
| P478 | volume | 4 |
| Q41665458 | Activity of superoxide dismutase copper/zinc type and prognosis in a cohort of patients with coronary artery disease |
| Q59566141 | Alterations in membrane fluidity of polymorphonuclear leukocytes from children with trisomy 21 |
| Q36227444 | Antioxidant activities and determination of phenolic compounds isolated from oriental plums (Soldam, Oishiwase and Formosa). |
| Q36126681 | Antioxidants in Down syndrome |
| Q52011655 | Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. |
| Q43723779 | Apoptosis in Down's syndrome: lessons from studies of human and mouse models |
| Q35677159 | Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome |
| Q36367840 | Bach1 overexpression in Down syndrome correlates with the alteration of the HO-1/BVR-a system: insights for transition to Alzheimer's disease |
| Q60192923 | Congenital disorders sharing oxidative stress and cancer proneness as phenotypic hallmarks: prospects for joint research in pharmacology |
| Q41712637 | Correlations of glutathione peroxidase activity with memory impairment in adults with Down syndrome |
| Q67902598 | Decreased oxidant-induced proteolysis in erythrocytes with enhanced antioxidative defence enzymes due to Down's syndrome |
| Q84523946 | Down syndrome and dementia: a randomized, controlled trial of antioxidant supplementation |
| Q44075352 | Dynamic and biphasic modulation of nitrosation reaction by superoxide dismutases. |
| Q31961712 | Effect of overexpression of wild-type and mutant Cu/Zn-superoxide dismutases on oxidative damage and antioxidant defences: relevance to Down's syndrome and familial amyotrophic lateral sclerosis |
| Q34405307 | Extensive natural variation for cellular hydrogen peroxide release is genetically controlled |
| Q40781838 | Free radicals in disease processes: a compilation of cause and consequence |
| Q44414213 | GVS-111 prevents oxidative damage and apoptosis in normal and Down's syndrome human cortical neurons. |
| Q40403790 | Importance of mitochondrial superoxide dismutase expression in insulin-producing cells for the toxicity of reactive oxygen species and proinflammatory cytokines. |
| Q35234195 | Intracellular oxidant activity, antioxidant enzyme defense system, and cell senescence in fibroblasts with trisomy 21. |
| Q59489064 | Melatonin reduces oxidative neurotoxicity due to quinolinic acid: |
| Q34335212 | Melatonin, hydroxyl radical-mediated oxidative damage, and aging: a hypothesis |
| Q37947197 | Mitochondrial dysfunction and Down's syndrome: is there a role for coenzyme Q(10) ? |
| Q44800097 | Neutrophil oxidative metabolism in Down syndrome patients with congenital heart defects |
| Q36761247 | Neutrophil-catalysed dimerisation of tyrosyl peptides |
| Q48095998 | Nutrient and toxin interactions in neurodegenerative disease |
| Q34348724 | Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury |
| Q48202977 | Pharmacological aspects of N-acetyl-5-methoxytryptamine (melatonin) and 6-methoxy-1,2,3,4-tetrahydro-beta-carboline (pinoline) as antioxidants: reduction of oxidative damage in brain region homogenates |
| Q42427621 | Puerarin protects against damage to spatial learning and memory ability in mice with chronic alcohol poisoning |
| Q44378538 | Relevance of drug uptake, cellular distribution and cell membrane fluidity to the enhanced sensitivity of Down's syndrome fibroblasts to anticancer antibiotic-mitoxantrone |
| Q35009522 | Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease--radicals or ridiculous? |
| Q34400646 | Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment |
| Q48428528 | Stress, aging, and neurodegenerative disorders. Molecular mechanisms |
| Q40282739 | Superoxide dismutase 1 modulates expression of transferrin receptor. |
| Q43173183 | Superoxide dismutase, lipid peroxidation, and bell-shaped dose response curves |
| Q44321229 | Targets of oxidative stress in yeast sod mutants |
| Q64777663 | The Shape of Mitochondrial Dysfunction in Down Syndrome |
| Q35031372 | The role of the cellular antioxidant defense in oxidant carcinogenesis |
| Q52069837 | Thermosensitivity of red blood cells from Down's syndrome individuals. |
| Q52039099 | Why does SOD overexpression sometimes enhance, sometimes decrease, hydrogen peroxide production? A minimalist explanation. |
Search more.